Published January 1, 2015 | Version v1
Journal article Open

Intravitreal bevacizumab monotherapy for type-1 prethreshold, threshold, and aggressive posterior retinopathy of prematurity-27 month follow-up results from Turkey

  • 1. Zeynep Kamil Gynocol & Pediat Educ & Res Hosp, Turkish Republ Minist Hlth, Istanbul, Turkey
  • 2. Istanbul Univ, Affiliated Hosp, Surp Pirg Armenian Fdn Hosp, TR-34020 Istanbul, Turkey

Description

To study the efficacy of intravitreal bevacizumab (IVB) injection as a single treatment for retinopathy of prematurity (ROP).

Files

bib-f3b4bec4-57d2-4b79-892b-bcba3eea29c9.txt

Files (301 Bytes)

Name Size Download all
md5:fc9ee88e798de2fad4d38dca90dc775f
301 Bytes Preview Download